Communication capacity scale and agitation distress scale to measure the severity of delirium in terminally ill cancer patients: A validation study

Palliative Medicine

Volumn 15, Issue 3, 2001, Pages 197-206

  Morita, Tatsuya ^a   Tsunoda, Junichi ^a   Inoue, Satoshi ^a   Chihara, Satoshi ^a   Oka, Kiyoshi ^a  

^a Seirei Mikatabara Hospital   (Japan)

Author keywords

Delirium; Measurement; Neoplasms; Palliative care

Indexed keywords

AGITATION DISTRESS SCALE; ARTICLE; CANCER PATIENT; CLINICAL RESEARCH; COGNITION; COMMUNICATION CAPACITY SCALE; CONTROLLED STUDY; DELIRIUM; DELIRIUM RATING SCALE; DISEASE SEVERITY; HUMAN; INTERPERSONAL COMMUNICATION; MEASUREMENT; MEMORIAL DELIRIUM SCALE; PALLIATIVE THERAPY; PRINCIPAL COMPONENT ANALYSIS; RATING SCALE; RELIABILITY; SCORING SYSTEM; SEDATION SCALE; SYMPTOM; TERMINALLY ILL PATIENT; VALIDATION PROCESS;

ADULT; AGED; AGED, 80 AND OVER; ANXIETY; COMMUNICATION; DELIRIUM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; OBSERVATION; PSYCHOMETRICS; SEVERITY OF ILLNESS INDEX; TERMINALLY ILL;

EID: 0035015304     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1191/026921601678576185     Document Type: Article

References (19)

1. Massie MJ, Holland J, Glass E. Delirium in terminally ill cancer patients. Am J Psychiatry 1983; 140: 1048-50.
2. Pereira J, Hanson J, Bruera E. The frequency and clinical course of cognitive impairment in patients with terminal cancer. Cancer 1997; 79: 835-42.
3. Jenkins C, Bruera E. Conflicts between family and staff: diagnosis, management, and prevention. In: Portenoy RK, Bruera E eds. Topics in palliative care, Volume 2. New York: Oxford University Press, 1998: 311-25.
4. Breitbart W, Rosenfeld B, Roth A, Smith MJ, Cohen K, Passik S. The Memorial Delirium Assessment Scale. J Pain Symptom Manage 1997; 13: 128-67.
5. Trzepacz PT, Baker RW, Greenhouse J. A symptom rating scale for delirium. Psychiatry Res 1998; 23: 89-97.
6. Jones CL, King MB, Speck P, Kurowska A, Tookman AJ. Development of an instrument to measure terminal restlessness. Palliat Med 1998; 12: 99-104.
7. Smith MJ, Breitbart WS, Platt MM. A critique of instruments and methods to detect, diagnose, and rate delirium. J Pain Symptom Manage 1994; 10: 35-77.
8. Riker R, Fraser GL, Cox PM. Continuous infusion of haloperidol controls agitation in clinically ill patients. Crit Care Med 1994; 22: 433-40.
9. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edition; DSM-IV. Washington, DC: American Psychiatric Association. 1994.
10. Fainsinger R, Miller MJ, Bruera E et al. Symptom control during the last week of life on a palliative care unit. J Palliat Care 1991; 7: 5-11.
11. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Manage 1998; 16: 145-52.
12. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedatives in a hospital support team and in a hospice. Palliat Med 1997; 11: 140-44.
13. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Manage 1996; 12: 32-38.
14. Ventafridda V, Ripamonti C, De Connno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 1990; 6(3): 7-11.
15. Folstein MF, Folstein S, McHugh PR: 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198.
16. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Palliat Med 1998; 12: 255-69.
17. Fondras JC. Sedation and ethical contradiction. Eur J Palliat Care 1996; 3: 17-20.
18. Morita T, Tsunoda J, Inoue S, Chihara S. The decision-making process in sedation for symptom control in Japan. Palliat Med 1999; 13: 262-64.
19. Cherny NI, Portenoy RK. Sedation in the management of refractory symptoms; guidelines for evaluation and treatment. Palliat Care 1994; 10(2): 31-38.